Yes... LOL. A couple months ago it seemed evident that former insiders & investors were exerting some pressure to resume trading. But nothing ever seems to happen, other than occasional SEC filings that state some objective -- which then falls into the black hole that is their communications. Continued deafening silence from the CEO, and no updates on the only thing that really matters, which is if and when the clinical trials will ever start. So who knows. Are they just going to burn through another $3 million in darkness and silence, announcing nothing and filing required SEC documents? March will turn into April, which will become May and then June. And we'll be sitting in front of our computers asking the same questions. I suppose if those insiders and investors decide to blow it all up with lawyers, that could make a difference (though it would be the end of the road for most of us). It's not clear that the company has any intention to do anything real, unless forced to do so. They might not like to read that, but what do they expect when they don't communicate, outside of required boilerplate filings?
